Clifford Hudis is the chief executive officer of the American Society of Clinical Oncology (ASCO). He also serves as the CEO of the ASCO Conquer Cancer Foundation and the chairman of the Board of Governors of ASCO’s CancerLinQ.
Before transitioning full-time to ASCO, Dr. Hudis was the chief of the Breast Medicine Service at Memorial Sloan Kettering Cancer Center in New York City, where he was also professor of medicine at the Weill Medical College of Cornell University. In this role, he developed more effective treatments for all stages of breast cancer, while also exploring novel prevention opportunities.
Dr. Hudis received his B.A. from Lehigh University and his M.D. from the Medical College of Pennsylvania in 1983. From 1983 through 1987 he trained in internal medicine at the Medical College of Pennsylvania and served as chief medical resident.
Dr. Hudis has served in a number of other capacities at ASCO and as a member of the editorial boards of several journals. He is a member of the Breast Committees of the Radiation Therapy Oncology Group and the National Comprehensive Cancer Network.
"By serving on the Professional Advisory Board of Breastcancer.org, I hope I can broaden the education and awareness for women with or worried about breast cancer," he says.
Can we help guide you?
Create a profile for better recommendations
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
Cancer Survivors Overestimate Quality of Their Diets
Most people who have been diagnosed with cancer think they eat a healthy diet, but a study found...